[Prolongation of oral anticoagulant treatment for eighteen months versus placebo at the decline of a first episode of idiopathic pulmonary embolism treated for six months: a randomized, multicentric, double blind trial. 2006 National PHRC (Hospital clinical research programme): "PADIS-EP/Prolongation of anticoagulant treatment for 18 months for a first episode of PE initially treated for 6 months"].

Francis Couturaud

doi:10.1016/j.pneumo.2008.09.012

Journal articles

[Prolongation of oral anticoagulant treatment for eighteen months versus placebo at the decline of a first episode of idiopathic pulmonary embolism treated for six months: a randomized, multicentric, double blind trial. 2006 National PHRC (Hospital clinical research programme): "PADIS-EP/Prolongation of anticoagulant treatment for 18 months for a first episode of PE initially treated for 6 months"].

Francis Couturaud ^{1, 2, *}

* Corresponding author

1 Service de Pneumologie

2 GETBO - Groupe d'Etude de la Thrombose de Bretagne Occidentale

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Human health and pathology

Complete list of metadatas

https://hal.univ-brest.fr/hal-00685681
Contributor : Ghislaine Calvez <>
Submitted on : Thursday, April 5, 2012 - 4:09:39 PM
Last modification on : Thursday, November 29, 2018 - 4:09:30 PM

Francis Couturaud. [Prolongation of oral anticoagulant treatment for eighteen months versus placebo at the decline of a first episode of idiopathic pulmonary embolism treated for six months: a randomized, multicentric, double blind trial. 2006 National PHRC (Hospital clinical research programme): "PADIS-EP/Prolongation of anticoagulant treatment for 18 months for a first episode of PE initially treated for 6 months"].. Revue de Pneumologie Clinique, Elsevier Masson, 2008, 64 (6), pp.332-6. ⟨10.1016/j.pneumo.2008.09.012⟩. ⟨hal-00685681⟩

Identifiers

Collections

Citation

Export

Metrics

66

Identifiers

Collections

Citation

Export

Share

Metrics

66